The Platform Meeting will take place on
Friday, 30th January 2026 13.30-15.00 CET

Register now

 

Evidence supports inflammation playing a role in Huntington’s disease pathogenesis. The mutant huntingtin protein disrupts immune cell function, centrally and peripherally.

Long before symptom onset, activated microglia and astrocytes can be detected and levels of pro-inflammatory molecules like IL-6 and TNF-α are found increased in CSF and plasma.

Far from being just a byproduct of neurodegeneration, inflammation could be an active driver of disease progression in HD, opening for anti-inflammatory therapies.
Join us to hear expert talks and a discussion panel addressing the question if it’s time to target Inflammation in HD.

Presentations by Prof. Roger Barker and Dr Niels Skotte will be followed by an expert panel discussion. The event will be chaired by Prof. Maria Björkqvist. All are very welcome to attend and ask questions.